Major histocompatibility complex (MHC) factors predisposing to and protecting against graves' Eye disease

Autoimmunity

Volumn 1, Issue 4, 1988, Pages 307-315

  Frecker, Maxine ^a   Mercer, Gregory ^a   Skanes, Verna M ^a   Farid, Nadir R ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Graves' eye disease; MHC

Indexed keywords

CANADA; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ETHNIC OR RACIAL ASPECTS; GRAVES DISEASE; HLA SYSTEM; HUMAN; HUMAN CELL; HUNGARY; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; PROTECTION;

DISEASE SUSCEPTIBILITY; EYE DISEASES; FEMALE; GRAVES' DISEASE; HAPLOTYPES; HLA ANTIGENS; HUMAN; MALE; NEWFOUNDLAND; ODDS RATIO; SUPPORT, NON-U.S. GOV'T;

EID: 0023748822     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916938809010684     Document Type: Article

References (38)

1. Autoimmune thyroid disease — a perspective
2. Familial goitre
3. Autoimmunity and Graves' ophthalmopathy
4. The pathogenesis of Graves' ophthalmopathy
5. Dysthyroid ophthalmopathy: orbital evaluation with B-scan ultrasonography
6. Appearance of Graves' disease on orbital computed tomography
7. Ophthalmopathy associated with primary hypothyroidism
8. Prevalence of increased intraocular pressure in Graves' disease — evidence of frequent subclinical ophthalmopathy
9. Exophthalmus in autoimmune thyroid disease
10. Demonstration of a circulating autoanti-body against a soluble eye-muscle antigen in Graves' ophthalmopathy
11. Monoclonal antibody studies defining the origin and properties of autoantibodies in Graves' disease
12. Immunological factors in thyroid disease
13. Graves' disease and HLA: Clinical and epideiologic associations
14. Classification of eye changes of Graves' disease
15. Modification of the classification of eye changes of Graves' disease: recommendations of the ad hoc committee of the American Thyroid Association
16. Genetic factors in Graves' opthalmopathy
17. Serotyping for homotransplation XVIII Refinement of microdroplet lymphocyte cytoxicity test
18. HLA and autoimmune endocrine disease
19. Population analysis of HLA-A, B, C, DR and other genetics
20. Bf types and HLA haplotyped individuals in an isolated Newfoundland population
21. Inherited structural polymorphism of the fourth component of human complement (C4)
22. Class III Alleles and High-risk MHC Haplotypes in Type I Diabetes Mellitus, Graves' Disease and Hashimoto's Thyroiditis
23. On estimating the relation between the blood groups and disease
24. HLA and disease 1982- A survey
25. Estimobility and estimation in case-referent studies
26. Structure, sequence and polymorphism in the HLA-D region
27. HLA and Graves' Disease: An association with HLA-DRw3
28. HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population
29. Genetic heterogeneity in thyrotoxicosis patients with and without endocrine ophthalmopathy
30. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy
31. Evidence for three types of human cytotoxic lymphocytes
32. Retrobulbar connective tissue changes in malignant exophthalmos
33. Orbital pathology in Graves' disease
34. Cell-mediated immunity in the exophthalmus of Graves' disease as demonstrated by migration inhibition factor (MIF) test
35. Demonstration of delayed hypersensitivity in retrobulbar and thyroid tissues in human exophthalmus
36. The genetic basis of susceptibility to autoimmune disease
37. HLA control of thyroglobulin-induced blast-transformation in Graves' disease